ArticleNature cancer2024

LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features.

Tian-Gen Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.